Staphylococcus aureus is able to generate resistance to novel lipoglycopeptide antibiotic gausemycin A

Gausemycin A is the first member of the novel lipoglycopeptides family produced by Streptomyces roseoflavus INA-Ac-5812. Gausemycin A has a pronounced bactericidal activity against methicillin-resistant Staphylococcus aureus. However, the ability of S. aureus to be resistant to gausemycin A has not...

Descripción completa

Detalles Bibliográficos
Autores principales: Poshvina, Darya V., Dilbaryan, Diana S., Kasyanov, Sergey P., Sadykova, Vera S., Lapchinskaya, Olda A., Rogozhin, Eugene A., Vasilchenko, Alexey S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558223/
https://www.ncbi.nlm.nih.gov/pubmed/36246291
http://dx.doi.org/10.3389/fmicb.2022.963979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558223/
https://www.ncbi.nlm.nih.gov/pubmed/36246291
http://dx.doi.org/10.3389/fmicb.2022.963979

Ejemplares similares